IDiyas

For the Inventor, By the Inventor

Ramat Hasharon, Israel

Illana Gozes

USPTO Granted Patents = 29 

 

Average Co-Inventor Count = 2.7

ph-index = 10

Forward Citations = 272(Granted Patents)


Location History:

  • Ness Ziona, IL (1992)
  • Tel Aviv, IL (1998)
  • Ramat, Hasharon, IL (2003)
  • Hasharon, IL (2007)
  • Ramat Hasharon, IL (1993 - 2021)

Company Filing History:

goldMedal15 out of 768 
 
Ramot at Tel-aviv University Ltd.
 patents
silverMedal5 out of 3,435 
 
National Institutes of Health, a Component of the US Dept. of Health & Human Services
 patents
bronzeMedal3 out of 1,167 
 
Yeda Research and Development Co. Ltd.
 patents
4. 3 out of 59 
 
Ramot University Authority for Applied Research and Industrial
 patents
5. 2 out of 2 
 
Allon Therapeutics, Inc.
 patents
6. 1 out of 71 
 
Ramot University Authority for Applied Research and Industrial Development Limited
 patents
7. 1 out of 1,215 
 
The United States of America As Represented by the Department of Health
 patents
8. 1 out of 2,202 
 
The United States of America As Represented by the Secretary of
 patents
9. 1 out of 16 
 
National Institute of Health
 patents
10. 1 out of 4 
 
Ramot-university Authority for Applied Research and Development Ltd.
 patents
11. 4 out of 832,680 
Other
 patents
where one patent can have more than one assignee

Years Active: 1992-2021

Loading Chart...
Loading Chart...
29 patents (USPTO):
1. 10912819 - Neuroprotective peptides derived from activity-dependent neuroprotective protein for treatment of neurological diseases (2021-02-09),
2. 10822375 - Method for identifying a modulator of cell survival or plasticity (2020-11-03),
3. 10118943 - Compounds and methods for inhibiting cell death (2018-11-06),
4. 9518994 - Method for diagnosing and monitoring schizophrenia and tauopathies (2016-12-13),
5. 8618043 - Use of ADNF polypeptides for treating anxiety and depression (2013-12-31),
6. 8586548 - NAP alpha-aminoisobutyric acid analog with neuroprotective activity (2013-11-19),
7. 8377875 - Therapeutics based on tau/microtubule dynamics (2013-02-19),
8. 8324166 - Neuroprotection using NAP-like and SAL-like peptide mimetics (2012-12-04),
9. 8143221 - Use of ADNF polypeptides for treating peripheral neurotoxicity (2012-03-27),
10. 8067369 - Protection of the retina against laser injury by NAP and related peptides (2011-11-29),
11. 8017578 - Orally active peptides that prevent cell damage and death (2011-09-13),
12. 7960334 - Use of ADNF III polypeptides for treating mental diseases and disorders, including schizophrenia (2011-06-14),
13. 7863247 - Prevention of fetal alcohol syndrome and neuronal cell death with ADNF polypeptides (2011-01-04),
14. 7452867 - Use of ADNF polypeptides for treating peripheral neurotoxicity (2008-11-18),
15. 7427598 - Post-natal administration of activity-dependent neurotrophic factor-derived polypeptides for enhancing learning and memory (2008-09-23),

Title: Illuminating the Mind: The Innovative World of Inventor Illana Gozes

Introduction: Illana Gozes is a renowned inventor hailing from Ramat Hasharon, Israel, known for his remarkable contributions in the field of neuroprotection and cell survival. With an impressive portfolio of 29 patents, Gozes continues to revolutionize the treatment of neurological diseases through his groundbreaking inventions.

Latest Patents:

1. "Neuroprotective peptides derived from activity-dependent neuroprotective protein for treatment of neurological diseases": Gozes' invention offers a cutting-edge formulation for delivering neuroprotective peptides effectively, targeting conditions such as autism, schizophrenia, and dementia.

2. "Method for identifying a modulator of cell survival or plasticity": This patent introduces novel compounds and methods for enhancing cell survival and plasticity, particularly in neuronal cells, by focusing on microtubule End Binding (EB) proteins and associated molecules.

Career Highlights: Gozes has made significant contributions to the scientific community through his work at Ramot at Tel-Aviv University Ltd. and The United States of America, represented by the Department of Health and Human Services. His dedication to advancing knowledge in the realms of neuroprotection and cell survival has earned him widespread recognition and acclaim.

Collaborations: Throughout his illustrious career, Gozes has collaborated with esteemed professionals such as Douglas E. Brenneman and Catherine Y. Spong. Together, they have spearheaded innovative research projects that have paved the way for new discoveries in the field of neuroscience.

Conclusion: Illana Gozes stands as a beacon of inspiration in the world of inventions and innovations, continuously pushing boundaries to improve the lives of individuals affected by neurological disorders. His unwavering commitment to scientific excellence and relentless pursuit of knowledge underscore his status as a visionary inventor in the realm of neuroprotection.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…